218 related articles for article (PubMed ID: 38167865)
21. A novel screen for nuclear mitochondrial gene associations with Parkinson's disease.
Mellick GD; Silburn PA; Prince JA; Brookes AJ
J Neural Transm (Vienna); 2004 Feb; 111(2):191-9. PubMed ID: 14767722
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial SNPs associated with Japanese centenarians, Alzheimer's patients, and Parkinson's patients.
Takasaki S
Comput Biol Chem; 2008 Oct; 32(5):332-7. PubMed ID: 18468491
[TBL] [Abstract][Full Text] [Related]
23. Mitochondria: A Therapeutic Target for Parkinson's Disease?
Luo Y; Hoffer A; Hoffer B; Qi X
Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial DNA polymorphisms and haplogroups in Parkinson's disease and control individuals with a similar genetic background.
Latsoudis H; Spanaki C; Chlouverakis G; Plaitakis A
J Hum Genet; 2008; 53(4):349-356. PubMed ID: 18286226
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial Complex I Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease.
Milanese C; Tapias V; Gabriels S; Cerri S; Levandis G; Blandini F; Tresini M; Shiva S; Greenamyre JT; Gladwin MT; Mastroberardino PG
Antioxid Redox Signal; 2018 Jan; 28(1):44-61. PubMed ID: 28816057
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2.
Casadei N; Sood P; Ulrich T; Fallier-Becker P; Kieper N; Helling S; May C; Glaab E; Chen J; Nuber S; Wolburg H; Marcus K; Rapaport D; Ott T; Riess O; Krüger R; Fitzgerald JC
Hum Mol Genet; 2016 Feb; 25(3):459-71. PubMed ID: 26604148
[TBL] [Abstract][Full Text] [Related]
27. Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease.
Langley MR; Ghaisas S; Palanisamy BN; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Exp Neurol; 2021 Jul; 341():113716. PubMed ID: 33839143
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease.
Flønes IH; Toker L; Sandnes DA; Castelli M; Mostafavi S; Lura N; Shadad O; Fernandez-Vizarra E; Painous C; Pérez-Soriano A; Compta Y; Molina-Porcel L; Alves G; Tysnes OB; Dölle C; Nido GS; Tzoulis C
Nat Commun; 2024 Apr; 15(1):3631. PubMed ID: 38684731
[TBL] [Abstract][Full Text] [Related]
29. Enhanced J-protein interaction and compromised protein stability of mtHsp70 variants lead to mitochondrial dysfunction in Parkinson's disease.
Goswami AV; Samaddar M; Sinha D; Purushotham J; D'Silva P
Hum Mol Genet; 2012 Aug; 21(15):3317-32. PubMed ID: 22544056
[TBL] [Abstract][Full Text] [Related]
30. Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency.
Gatt AP; Duncan OF; Attems J; Francis PT; Ballard CG; Bateman JM
Mov Disord; 2016 Mar; 31(3):352-9. PubMed ID: 26853899
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial superclusters influence age of onset of Parkinson's disease in a gender specific manner in the Cypriot population: A case-control study.
Georgiou A; Demetriou CA; Heraclides A; Christou YP; Leonidou E; Loukaides P; Yiasoumi E; Panagiotou D; Manoli P; Thomson P; Loizidou MA; Hadjisavvas A; Zamba-Papanicolaou E
PLoS One; 2017; 12(9):e0183444. PubMed ID: 28877188
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial dysfunction in Parkinson's disease.
Schapira AH
Cell Death Differ; 2007 Jul; 14(7):1261-6. PubMed ID: 17464321
[No Abstract] [Full Text] [Related]
33. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.
Devi L; Raghavendran V; Prabhu BM; Avadhani NG; Anandatheerthavarada HK
J Biol Chem; 2008 Apr; 283(14):9089-100. PubMed ID: 18245082
[TBL] [Abstract][Full Text] [Related]
34. Differential Effects of Yeast NADH Dehydrogenase (Ndi1) Expression on Mitochondrial Function and Inclusion Formation in a Cell Culture Model of Sporadic Parkinson's Disease.
Cronin-Furman EN; Barber-Singh J; Bergquist KE; Yagi T; Trimmer PA
Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30934776
[TBL] [Abstract][Full Text] [Related]
35. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
[TBL] [Abstract][Full Text] [Related]
36. Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of Parkinson's disease.
Wang XL; Feng ST; Wang YT; Zhang NN; Guo ZY; Yan X; Yuan YH; Wang ZZ; Chen NH; Zhang Y
Phytomedicine; 2022 Sep; 104():154281. PubMed ID: 35752080
[TBL] [Abstract][Full Text] [Related]
37. Peptides derived from small mitochondrial open reading frames: Genomic, biological, and therapeutic implications.
Miller B; Kim SJ; Kumagai H; Mehta HH; Xiang W; Liu J; Yen K; Cohen P
Exp Cell Res; 2020 Aug; 393(2):112056. PubMed ID: 32387288
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial dysfunction in Parkinson's disease.
Winklhofer KF; Haass C
Biochim Biophys Acta; 2010 Jan; 1802(1):29-44. PubMed ID: 19733240
[TBL] [Abstract][Full Text] [Related]
39. The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.
Müller-Nedebock AC; Brennan RR; Venter M; Pienaar IS; van der Westhuizen FH; Elson JL; Ross OA; Bardien S
Neurochem Int; 2019 Oct; 129():104495. PubMed ID: 31233840
[TBL] [Abstract][Full Text] [Related]
40. V-MitoSNP: visualization of human mitochondrial SNPs.
Chuang LY; Yang CH; Cheng YH; Gu DL; Chang PL; Tsui KH; Chang HW
BMC Bioinformatics; 2006 Aug; 7():379. PubMed ID: 16907992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
